Impiricus Raises $3M in Seed Funding Led by FCA Venture Partners

By Impiricus
May 23, 2022

In 2022, Impiricus closed a $3 million Series Seed financing round led by FCA Venture Partners, with participation from Surface Ventures.

“Impiricus clearly fits our investment thesis,” said Todd Johnson, Partner at FCA Venture Partners. “A bold leadership team with a powerful product and the potential to reshape pharma-HCP collaboration.”

The funding supports our ongoing mission to transform healthcare communication by connecting physicians and pharma through real-time, ethical, AI-powered technology.

From Noise to Value: Ending Content Overload for Physicians

What banning direct-to-consumer pharma ads would mean for doctors

What the FDA’s DTC drug ad crackdown means for pharma companies